Related Tags >> Bristol-Myers Squibb Melanoma Medarex Yervoy

ipilimumab News

Most Popular ipilimumab Story

The next generation of biotech blockbusters

July 8, 2008 — 2:51pm ET | By Maureen Martino

The 2007 rate of new biologic approvals was slow, with only a handful of drugs squeaking through FDA review. But the pace is set to pick up in 2008. According to IMS Health, these biologics could Read more...

ipilimumab Press Releases

Medical Oncologists Have Rapidly Adopted Yervoy and Zelboraf in All Lines of Therapy for the Treatment of Metastatic Melan
Celldex Expands Senior Management Team with Appointment of Dr. Ronald A. Pepin, Senior Vice President and Chief Business O
Phase III Study of Investigational Compound Ipilimumab Achieves Primary Endpoint of Improvement in Overall Survival in
Bristol-Myers Squibb Announces that the U.S. Food and Drug Administration Has Extended the Review Timeline for the Ipilimumab Bi
Bristol-Myers Squibb Second Quarter Featured Robust Clinical Data and Double-Digit EPS Growth

Latest Headlines

Bristol-Myers grabs EU approval of key melanoma drug
July 14, 2011
BMS, Roche join forces and drugs on combo melanoma program
June 2, 2011
FDA hands Bristol a blockbuster approval for breakthrough cancer drug
March 28, 2011
Ipilimumab: Timeline of a melanoma drug
March 25, 2011
FDA approves Bristol's Yervoy (ipilimumab) for melanoma
March 25, 2011
FDA nears deadline on closely-watched melanoma drug
March 24, 2011
Bristol's breakthrough melanoma drug delivers promising data in Ph3
March 22, 2011
FDA delays decision on BMS cancer drug ipilimumab
November 2, 2010
Ipilimumab - FDA's Top 10 Blockbuster Decisions
October 11, 2010
Benlysta, BMS melanoma drug win accelerated FDA review
August 19, 2010
BMS, Pfizer cancer drugs take starring roles at ASCO
June 7, 2010
After lengthy delay, BMS plans starring ASCO role for melanoma drug
May 28, 2010
Bristol-Myers to buy Medarex for $2.1B
July 23, 2009
Medarex shares rise on surprising cancer study
June 22, 2009
Ipilimumab - Next gen biotech blockbusters
July 8, 2008
The next generation of biotech blockbusters
July 8, 2008
Medarex shares dented on analysts' skepticism
June 3, 2008
Medarex shares slide on news of drug app delay
April 28, 2008

Paid Research Reports

More Research Reports >>

Free Newsletter

Most Popular Stories

Webinars

Hottest Products

Featured Jobs

Events